- This item is classified as 'functional colonic disease' in MONDO and falls under the category of functional colonic diseases linked to the MedlinePlus overview of Irritable Bowel Syndrome (IBS).
- The exact cause has not been established, and factors related to symptoms may vary from person to person.
- It is generally understood that symptoms are influenced by a complex interplay of gut-brain interaction, gastrointestinal motility, visceral sensation, and stress responses.
- Representative manifestations include abdominal cramping or pain, abdominal bloating, and changes in bowel habits such as constipation, diarrhea, or alternating between the two.
- The MedlinePlus overview states that it is more common in women and primarily found in individuals under 45 years of age, but individual risks and manifestations vary.
- Symptoms may recur or fluctuate, and discomfort can be significant, but IBS itself is not described as a disease that damages the intestines.
- Rather than confirming a diagnosis with a single specific test, symptoms and medical history are evaluated, and if necessary, other diseases are ruled out through stool/blood tests, imaging, colonoscopy, or sigmoidoscopy.
- Since other intestinal diseases cannot be excluded based on symptoms alone, newly onset symptoms or atypical findings must be evaluated separately.
- The broad framework of management includes dietary adjustments tailored to symptom patterns, stress management, lifestyle assessment, and the use of medication or probiotics if necessary.
- The goal of treatment is not to apply the same approach to everyone, but to reduce primary symptoms such as pain and bowel dysfunction and to support daily functioning.